The company's non-surgical therapy device, developed from Stanford University's Biodesign program, offers a drug-free solution for accidental bowel leakage in patients with pelvic floor disorders. Pelvalon is committed to finding simple solutions to difficult problems and improving the quality of life for women. The company is privately held and has received funding from Norwich Ventures, a venture capital firm focused on medical technology.